SCR Pharmatop's IV Paracetamol Patent Gets Revoked by the IPO

In a landmark decision, the Indian Patent Office has decided in favor of Venus Remedies with regards to a matter concerning the IV Paracetamol patent. Venus Remedies had challenged SCR Pharmatop’s patent citing that the patent did not comprise of any inventive step. Read more: https://bit.ly/3DIyIGy